Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06376994

Multi-Center Clean Air Randomized Controlled Trial in COPD

This is a multi-center randomized, sham-controlled clinical trial to determine the effectiveness of an air cleaner intervention aimed at improving indoor air quality on reducing COPD exacerbation risk and improving quality of life, functional status, rescue medication use.

Recruiting

Interested in participating?

Request Info

Key information

Age range

40 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

University of Alabama, Lung Health Center, Birmingham, Alabama, United States

Loading trial locations.

About this study

The Multi-Center Clean Air Randomized Controlled Trial in COPD (Clean Air) is a multi-center, prospective, randomized, double-blind, sham-controlled trial that will enroll 770 former smokers with COPD over a 4-year period and follow participants at regular intervals for one year. The primary endpoint is respiratory specific quality of life. Secondary endpoints include rate of acute exacerbations, rescue medication use, quality of life, and cost-effectiveness.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

To be eligible, subjects must meet all these criteria:

  • Age ≥ 40 years.
  • Self-report of physician diagnosis of COPD.
  • Spirometry confirmed airway obstruction (post-bronchodilator spirometry of forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) < 0.7) as defined by the Global Initiative for Obstructive Lung Disease (GOLD) criteria (6, 11)
  • Tobacco exposure ≥ 10 pack-years. This refers to regular cigarette tobacco consumption.
  • Self-reported former smoker of at least 6 months' duration. This does not include e-cigarette use.
  • COPD Assessment Test (CAT) score ≥ 10, Modified Medical Research Council dyspnea scale (mMRC) ≥ 2, or history of moderate or severe exacerbation in the past 12 months (as defined by history of receiving a course of systemic corticosteroids or antibiotics for respiratory problems; or visiting an emergency department or being hospitalized for a COPD exacerbation within the past 12 months.)

Exclusion criteria

To be eligible, subjects must not meet any one of these criteria:

  • Living in a location other than home (e.g., long-term care facility, nursing home)
  • Other chronic lung diseases, except asthma
  • Condition with less than a year of life expectancy (e.g., metastatic cancer) or in hospice
  • Spends >2 months per year in location other than home; or plans to change residence in the next 12 months
  • Pregnant or breastfeeding
  • Current air cleaner use in the home (*If the individual is willing to discontinue use of the personal air cleaner, this person can be eligible if all other eligibility has been met)
  • Inability to bring air cleaners (about 15 pounds each) into home, either by self, friend, or relative
  • Deemed by the study investigator to be unable to complete study protocol, including likely lack of internet connectivity
  • Participating in another interventional clinical trial

Treatment and study plan

Air cleaner

Device

The intervention is two active air cleaners with high efficiency particulate air (HEPA) filters which remove PM, as well as activated carbon filters to remove NO2 (and other trace gases). These will be run for a year in a participant's house.

Sham air cleaner

Device

The sham intervention is two sham air cleaners that have the internal HEPA and carbon filters removed, but which will run normally, including similar noise, airflow, and overall appearance compared to active air cleaners, thus blinding participants to filter status. These will be run for a year in a participant's house.

Primary outcomes

  1. St. George's Respiratory Questionnaire (SGRQ)

    Time frame: baseline and 3, 6, 9, and 12 months after baseline

    The St. George's Respiratory Questionnaire (SGRQ) is a widely used measure of disease impact as an indicator of disease-specific quality of life. The SGRQ is a disease specific instrument containing 50 items in three subscales (symptoms, activity, and impact). Scores range from 0 to 100, with higher scores indicating more limitations.

Study contacts

Contact information is provided by the study sponsor or research team.

Stephan Ehrhardt, MD, PhD

CONTACT

[email protected]

(410) 502-3872

Sponsors and collaborators

Lead sponsor

JHSPH Center for Clinical Trials

Other

Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

Registry information

Acronym: Clean Air

Important dates

Study start
2024
Primary completion
2029
Study completion
2029
First posted
Apr 22, 2024
Registry last updated
Jul 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.